CAS: 1743-60-8; (8R,9S,13S,14S,17S)-3-Hydroxy-13-Methyl-7,8,9,11,12,13,14,15,16,17-Decahydro-6H-Cyclopenta[a]Phenanthren-17-Yl Acetate

上下游产品

CAS号2394-16-3 Estra-1,3,5(10)... | CAS号50-28-2 雌二醇 | CAS号141-78-6 乙酸乙酯 | CAS号1425-10-1 19-去甲睾酮乙酸盐 | CAS号108-24-7 乙酸酐 | CAS号23880-55-9 17β-Acetoxy-3-b... | CAS号14982-15-1 3-O-Benzyl Estradiol | CAS号53-16-7 雌酚酮 | CAS号88378-62-5 Estra-1,3,5(10)... | CAS号144082-87-1 [(8R,9S,13S,14S... | CAS号50-28-2 雌二醇 | CAS号5976-61-4 4-羟基雌二醇 | CAS号15270-30-1 17β-雌二醇 3β-D-葡糖苷酸

📜雌酚酮置于platinum(Iv) Oxide 盐酸,Sodium Hydroxide,氢碘酸,氢气体系中,用 乙醇 用作溶剂,化学反应生成17Beta-雌二醇 17-乙酸酯
参考文献:17β-Oestradiol 17-Methyl Ether
标题:17β-Oestradiol 17-Methyl Ether
摘要:
Doi:10.1016/0039-128X(65)90103-0

专利信息

专利号:US-6350739-B1
优先权日:1999-08-11
标 题:Methods of prevention and treatment of ischemic damage
发明人：SIMPKINS JAMES W; COVEY DOUGLAS F
权利人:UNIV FLORIDA RESARCH FOUNDATIO; UNIV WASHINGTON
摘要:The present invention in various embodiments provides methods of treating stroke and conferring protection on a population of cells associated with ischemia in a subject following an ischemic event, comprising: (a) providing an estrogen compound; and (b) administering the effective amount of the compound over a course that includes at least one dose within a time that is effectively proximate to the ischemic event, so as to confer protection on the population of cells. Novel methods are provided for the delivery of an estrogen compound. Examples of ischemic events treatable according to the invention are cerebrovascular disease or stroke, subarachnoid subhemorrhage, myocardial infarct, surgery and trauma. A method of treating ischemic damage utilizing hormones that are non-sex hormones is also provided. A method of treating stroke with ent-17β-estradiol, and a method of synthesis, and compounds produced from the synthesis are provided.

专利号:US-6150403-A
优先权日:1997-10-14
标 题 :Topical compositions for regulating the oily/shiny appearance of skin
发明人：BIEDERMANN KIMBERLY A; SCHUBERT HARRY L; PARRAN JR JOHN J
权利人:PROCTER & GAMBLE
摘要:The present invention relates to methods for inhibiting sebaceous gland activity in mammalian skin comprising administration of a topical composition comprising dehydroacetic acid or pharmaceutically acceptable salts thereof, and a dermatologically-acceptable carrier. The present invention also relates to methods and topical compositions further comprising agents which regulate the oily and/or shiny appearance of skin, and agents which treat acne and related skin disorders in mammalian skin and scalp. Methods of reducing sebum synthesis with the use of dehydroacetic acid, methods of regulating the oily and/or shiny appearance of skin, and methods of treating acne and other skin disorders are also encompassed by the present invention.

专利号:US-5902603-A
优先权日:1995-09-14
标题 :Polyurethane hydrogel drug reservoirs for use in transdermal drug delivery systems, and associated methods of manufacture and use
发明人：CHEN TUNG-FEN; CHIANG CHIA-MING; JONA JANAN; JOSHI PRITI; RAMDAS ASHA
权利人:CYGNUS THERAPEUTIC SYSTEMS
摘要:High capacity drug reservoirs are provided for incorporation into transdermal drug delivery systems. The drug reservoirs are hydrogels formulated from polyurethanes crosslinked with diisocyanate crosslinking agents or cured with radiation in the presence of a photoinitator. Drug loading as high as 65 to 70 wt. % or higher can be achieved by absorbing drug formulation into the reservoir after hydrogel synthesis. Methods for making and using transdermal systems containing such reservoirs are provided as well.

专利号:US-4537722-A
优先权日:1983-05-30
标 题:Steroid esters preparation
发明人：STAMVIK ANDERS R; KRISTENSSON STEN K; LUNDVALL KARL-ERIK
权利人:LEO AB
摘要:This invention relates to an improved steroid ester synthesis in which carbodiimides and catalytic amounts of 4-(tertiary amino)-pyridines, in combination with acid catalysts, are used as condensing agents, resulting in pure, non discolored compounds in high yields.